FDA, Lilly Score Win in Weight Loss Drug Shortage Decision (1)

The FDA lawfully determined that Eli Lilly & Co.’s tirzepatide drug shortage ended and that drug compounders couldn’t keep making copies of the weight loss drug, a federal judge ruled.

Judge Mark T. Pittman of the US District Court for the Northern District of Texas agreed with the Food and Drug Administration that it lawfully removed tirzepatide from the drug shortage list last year, granting on Wednesday the agency’s motion for summary judgment.

The opinion is currently sealed but will eventually be redacted, according to the court’s docket.

The Outsourcing Facilities Association and compounding pharmacy FarmaKeio Custom Compounding alleged ...